11 Dec 2023
Afferent Medical Solutions, a UK-based bioelectronics medicine company developing novel device-based neuromodulation solutions for the treatment of circulatory system diseases and other therapeutic areas poorly served by existing medication, has successfully obtained from a Notified Body the ISO 13485 certification, marking a significant milestone in the company's commitment to excellence and adherence to rigorous quality standards
Afferent Medical Solutions, a UK-based bioelectronics medicine company developing novel device-based neuromodulation solutions for the treatment of circulatory system diseases and other therapeutic areas poorly served by existing medication, has successfully obtained from a Notified Body the ISO 13485 certification, marking a significant milestone in the company's commitment to excellence and adherence to rigorous quality standards